Comparison
22q11 2 Deletion Syndrome Cn294181 vs 2 Hydroxyphenylacetic Aciduria C5937087
Clinical comparison between 22q11 2 Deletion Syndrome CN294181 and 2 Hydroxyphenylacetic Aciduria for differential diagnosis and treatment planning.
22q11 2 Deletion Syndrome Cn294181
A genetic condition where a small piece of chromosome 22 is missing. It can affect the heart, immune system, and development. Treatment involves managing symptoms across multiple specialties.
2 Hydroxyphenylacetic Aciduria C5937087
A rare metabolic disorder where the body cannot properly process certain acids. It may cause neurological issues and is typically identified in infancy. Management involves diet modifications and supportive care.
6 comparison axes
Onset
22q11 2 Deletion Syndrome Cn294181
0-null
2 Hydroxyphenylacetic Aciduria C5937087
0-null
Onset patterns differ
Severity
22q11 2 Deletion Syndrome Cn294181
severe
2 Hydroxyphenylacetic Aciduria C5937087
moderate
Different severity levels
Chronic
22q11 2 Deletion Syndrome Cn294181
Chronic
2 Hydroxyphenylacetic Aciduria C5937087
Chronic
Differing course
Communicable
22q11 2 Deletion Syndrome Cn294181
No
2 Hydroxyphenylacetic Aciduria C5937087
No
Different transmission
Body System
22q11 2 Deletion Syndrome Cn294181
congenital
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Same/different system
Category
22q11 2 Deletion Syndrome Cn294181
genetic
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Different category
Bottom line
22q11-2-deletion-syndrome-CN294181 and 2-hydroxyphenylacetic-aciduria-C5937087 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 22q11 2 Deletion Syndrome Cn294181 | 2 Hydroxyphenylacetic Aciduria C5937087 | Discriminating power |
|---|---|---|---|
| Congenital pattern | May involve heart, immune function, and development from missing chromosome 22 material. | A congenital malformation pattern is not established in the supplied description. | High |
| Metabolic abnormality | Not defined by abnormal organic-acid processing. | Described as impaired processing of certain acids, often recognized in infancy. | High |
| Neurologic or developmental concern | Developmental effects may occur alongside other congenital features. | Neurological issues may occur, but the range is not established here. | Moderate |
When to favor each condition
Choose 22q11 2 Deletion Syndrome Cn294181 when
Multisystem congenital features suggest a chromosomal cause
Cardiac, immune, and developmental involvement fits the described deletion syndrome better than aciduria.
Moderate
Targeted genetic confirmation is needed
A chromosome 22 deletion test addresses the proposed genetic etiology.
High
An abnormal metabolite result lacks syndrome features
Do not assign 22q11.2 deletion without genetic evidence.
High
Choose 2 Hydroxyphenylacetic Aciduria C5937087 when
Infancy evaluation shows a relevant organic-acid abnormality
The finding requires metabolic interpretation rather than a chromosomal diagnosis.
Moderate
Neurologic symptoms accompany suspected acid-processing disorder
This matches the supplied metabolic description, pending confirmation.
Low
Management focuses on diet and supportive care
Those measures are described for the aciduria, not as deletion-specific treatment.
Moderate
How key tests differ
| Test | 22q11 2 Deletion Syndrome Cn294181 | 2 Hydroxyphenylacetic Aciduria C5937087 | Interpretation |
|---|---|---|---|
| 22q11.2 genetic testing | May detect a deletion when the syndrome is present. | Not expected to establish aciduria. | A genetic result confirms or excludes the deletion; it does not measure the metabolite. |
| Urine organic acids | No specific pattern is established by the supplied data. | May show 2-hydroxyphenylacetic acid elevation; no cutoff is supplied. | An abnormal result is not itself a complete diagnosis. |
| Cardiac and immune evaluation | Often relevant because heart and immune involvement may occur. | Not specifically indicated by the supplied description. | Select testing from the clinical picture and specialist review. |
Prognosis comparison
22q11 2 Deletion Syndrome Cn294181
- Outcome
- Often chronic and potentially severe, with wide individual variation.
- Factors
- Organ involvement, immune status, development, and coordinated care.
2 Hydroxyphenylacetic Aciduria C5937087
- Outcome
- Described as moderate and chronic, but prognosis is not well established.
- Factors
- Metabolic severity, neurologic effects, response to supportive care, and comorbidities.
Time frame: Lifelong follow-up may be needed; the exact course is not established.
Supplied severity labels are not individual predictions.
Complications comparison
| Complication | Presentation |
|---|---|
| Cardiac involvement | Congenital heart disease may occur. Cardiac complications are not established. Do not infer cardiac risk from aciduria alone. |
| Immune complications | Immune dysfunction and infections may occur. Immune involvement is not established. Infection history needs individual assessment. |
| Neurologic complications | Developmental differences may occur. Neurological issues may occur, with uncertain severity. Developmental follow-up depends on clinical findings. |
Patient education highlights
- HighDifferent conditions
One is a chromosome 22 deletion; the other is a rare metabolic acid-processing disorder or finding.
- HighDifferent tests
Genetic testing and urine organic-acid testing answer different clinical questions.
- MediumIndividual care
No universal diet, dose, or outcome is established here; follow clinician guidance.